Live Breaking News & Updates on Fund the company into fourth quarter

Stay informed with the latest breaking news from Fund the company into fourth quarter on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Fund the company into fourth quarter and stay connected to the pulse of your community

NeuroBo Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update

DA-1726 Phase 1 IND Filing Expected by Year End 2023
Board Strengthened with Recent Appointment of Industry Veteran, James P. Tursi, M.D.
Cash and Cash Equivalents of $25.8 Million, Expected to Fund...

United-states , Texas , Boston , Massachusetts , Marshall-woodworth , Michael-miller , Zeid-kayali , Jamesp-tursi , David-ramirez , Fund-the-company-into-fourth-quarter , Neurobo-pharmaceuticals , Nasdaq